Radioimmunoassay for urinary lysozyme in human serum from leukemic patients. 1978

T L Peeters, and Y R Depraetere, and G R Vantrappen

We present a radioimmunoassay for lysozyme in human serum, based upon human lysozyme isolated from the urine of leukemic patients and antiserum prepared against this lysozyme in the goat. In the separation step, a second antibody is used. By properly adjusting the concentrations of unlabeled and 125I-labeled lysozyme and of the antibodies, maximal precision (SD, 0.04 mg/litre) was obtained in the range 0.00 to 2.00 mg/litre. In 20 normal volunteers the lysozyme concentration was 4.6 +/- 0.8 mg/litre (mean +/- SD), in 13 patients with monocytic leukemia 34.4 +/- 8.6 mg/litre. Correlation with lysoplate determinations was excellent in leukemic sera (r = 0.97) but was poor in normal sera (r = 0.35), possibly owing to the existence of isoenzymes.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T L Peeters, and Y R Depraetere, and G R Vantrappen
July 1981, Clinical chemistry,
T L Peeters, and Y R Depraetere, and G R Vantrappen
January 1992, Journal of pharmaceutical and biomedical analysis,
T L Peeters, and Y R Depraetere, and G R Vantrappen
March 1973, Acta endocrinologica,
T L Peeters, and Y R Depraetere, and G R Vantrappen
September 1974, The Tohoku journal of experimental medicine,
T L Peeters, and Y R Depraetere, and G R Vantrappen
January 1971, Israel journal of medical sciences,
T L Peeters, and Y R Depraetere, and G R Vantrappen
July 1993, Annals of clinical biochemistry,
T L Peeters, and Y R Depraetere, and G R Vantrappen
May 1983, Clinical and experimental immunology,
T L Peeters, and Y R Depraetere, and G R Vantrappen
June 1974, Polskie Archiwum Medycyny Wewnetrznej,
T L Peeters, and Y R Depraetere, and G R Vantrappen
May 1990, Journal of pharmaceutical sciences,
T L Peeters, and Y R Depraetere, and G R Vantrappen
August 1978, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!